Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5)
申请人:Cumming John
公开号:US20050014788A1
公开(公告)日:2005-01-20
Compounds of formula (I): compositions comprising them, processes for preparing them and their use in medical therapy (for example modulating CCR5 receptor activity in a warm blooded animal).
Sunagawa et al., Yakugaku Zasshi/Journal of the Pharmaceutical Society of Japan, 1953, vol. 73, p. 879
作者:Sunagawa et al.
DOI:——
日期:——
Marchetti, Mauro; Sechi, Barbara; Azzena, Ugo, Anales de Quimica, 1998, vol. 94, # 4-5, p. 219 - 225
作者:Marchetti, Mauro、Sechi, Barbara、Azzena, Ugo、Botteghi, Carlo、Paganelli, Stefano、Ponte, Gino Del、Stefani, Helio A.
DOI:——
日期:——
PIPERIDINE DERIVATIVES AND THEIR USE AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY (ESPECIALLY CCR5)
申请人:AstraZeneca AB
公开号:EP1448524A1
公开(公告)日:2004-08-25
[EN] PIPERIDINE DERIVATIVES AND THEIR USE AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY (ESPECIALLY CCR5)<br/>[FR] DERIVES DE LA PIPERIDINE ET LEURS UTILISATIONS COMME MODULATEURS DE L'ACTIVITE DU RECEPTEUR DE LA CHEMOKINE (SPECIALEMENT DU CCR5)
申请人:ASTRAZENECA AB
公开号:WO2003042177A1
公开(公告)日:2003-05-22
Compounds of formula (I): compositions comprising them, processes for preparing them and their use in medical therapy (for example modulating CCR5 receptor activity in a warm blooded animal).